Innovative Biotech - Nassarawa, Nigeria

IBL specializes in developing and producing clinical vaccine batches for human trials, as well as contracting with vaccine manufacturers. To ensure the production of liquid or lyophilized vaccines in the right quantities for Phase III clinical trials, they have established a small-scale manufacturing facility. Additionally, they create, manufacture, and distribute on-site point-of-care screening and testing solutions.